OBJECTIVE: Bariatric surgery represents a powerful tool for morbid obesity treatment. However, after stabilization of weight loss that follows surgical interventions, ex-obese patients face the problem of residual tissues removal. Actually, it is unknown whether the characteristics of this residual subcutaneous adipose tissue (SAT) are 'restored' with regard to molecular and morphological features. DESIGN: To clarify this issue, we compared the SAT gene expression profile of ex-obese patients (ExOB-SAT, mean body mass index (BMI): 27.2 ± 1.3 kg m À 2 ) with that of lean (normal weight, NW-SAT, mean BMI: 22.6 ± 1.1 kg m ) and obese patients, according to BMI classes (OB1-SAT: 30XBMIp34.9, OB2-SAT: 35XBMIp39.9, OB3-SAT: BMIX40). SUBJECTS AND METHODS: A total of 58 samples of SAT were collected during surgical interventions. Gene expression levels were assessed by microarrays and significant genes were validated by RT-qPCR. Adipocyte hypertrophy, inflammatory infiltration and fibrosis were assessed by morphological techniques. RESULTS: Global gene expression in ExOB-SAT was closely related to gene expression of OB3-SAT by hierarchical clustering procedures, in spite of different BMI. Metallothioneins (MT1A and MT2A) were the key over-expressed genes in both groups. At morphologic level, adipocyte hypertrophy and inflammatory infiltration improved after weight loss in ExOB-SAT, despite a persistence of fibrosis. CONCLUSIONS: Taken together, these results demonstrate that SAT gene expression is not fully restored, even after an extensive and stable weight loss. The persistence of 'obesity molecular features' in ExOB-SAT suggests that the molecular signature of adipose tissue is not solely dependent on weight loss and may need longer time period to completely disappear.
INTRODUCTION
Overweight and obesity are the major risk factors for a wide number of chronic diseases, including diabetes, cardiovascular disease and cancer. Their prevalence is now dramatically raising worldwide. 1 From a biological point of view, obesity results from a combination of adipocyte hypertrophy/hyperplasia and it is associated with local and systemic inflammation and dysfunctions of extracellular matrix remodeling. 2, 3 These different pathogenetic mechanisms may underlie the variability of adipose tissue responsiveness to weight loss induced by dietary interventions, energy restricted diets and bariatric surgery. It is well known that bariatric surgery procedures induce a sustained and rapid weight loss improving most of the obesity-linked co-morbidities and decreasing the mortality, particularly from cardiovascular disease. [4] [5] [6] [7] [8] Following surgery-induced weight loss, body weight is usually stable for a period of at least 12-18 months 9 and ex-obese patients (ExOB) have, in the long term, physical consequences such as flabby skin, abdominal overhang and pendulous breast that often represents esthetic, as well as psychological disadvantages. 10, 11 For this reason, the number of plastic surgeries that follows bariatric interventions is now rapidly increasing. [12] [13] [14] [15] At present, the molecular and morphological features of the residual adipose tissue that is removed during plastic surgery that follows a massive weight loss is still largely unknown. To the best of our knowledge, only one report indicates that subcutaneous adipose tissue (SAT) of ExOB patients exhibits differences in blood vessel content as well as in resident mesenchymal stem cell population. 16 Aim of the present study is then to investigate, at both morphological and molecular level, subcutaneous abdominal adipose tissue (SAT) after massive weight loss in a group of ExOB patients.
MATERIALS AND METHODS

Subjects and adipose tissue biopsy
The study was approved by the Ethical Committee of Istituto Auxologico Italiano, Milano, Italy. The aims of this study were explained to each subject, who gave and signed an informed consent. Surgical biopsies of SAT were collected from a total of 58 subjects. Obese patients abdominal SAT from the periumbilical area was collected per-operatively in 30 1 subjects undergoing bariatric surgery as treatment for morbid obesity (Roux-en-Y gastric bypass), in 10 ex-obese patients (ExOB), undergoing dermolipectomy/abdominoplasty for esthetical reasons, in 10 overweight subjects (OW) and in 8 lean healthy subjects (NW, used as lean controls) who underwent laparoscopic surgical procedures for both non-inflammatory diseases and esthetic reasons. Ex-obese subjects had a stable weight with no fluctuations for at least 2 years before plastic surgery. Normal weight and OW subjects have never been obese in their life and were not affected by chronic diseases. The characteristics of the enrolled patients are summarized in Table 1 . Each collected biopsy was stored in a solution of 2.5% bovine serum albumine (Sigma, St Louis, MO, USA) in high glucose-DMEM (Invitrogen, Carlsbad, CA, USA) (1 ml per tissue gram) and immediately processed. Low tissue availability from OW subjects limited the analysis to the molecular signature of SAT by microarrays.
Isolation of RNA from SAT
From all 58 SAT collected samples, B500-800 mg of frozen adipose tissue was homogenized in RLT buffer (Qiagen, Milan, Italy) and transferred into a 2-ml centrifuge tubes. RNA from the SAT was extracted using the RNeasy Mini Kit (Qiagen) according to the manufacturer's protocol. Amount and quality of the extracted RNA were measured by NanoDropH ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA) and RNA integrity was then verified by gel-electrophoresis.
Gene expression analysis by microarray
A total of 33 SAT samples was used for microarrays (NW, Table 1 ). Gene expression profile was evaluated using HumanHT-12 v3 BeadChips wholegenome hybridization assay (Illumina, San Diego, CA, USA), which is based upon fluorescence detection of biotin-labeled cRNA. Each array contains full-length 50-mer probes representing 448 000 well-annotated RefSeq transcripts, including 425 400 unique, curated, and up-to-date genes derived from the National Center for Biotechnology Information Reference Sequence database. Initially, 300 ng of total RNA was converted to cDNA, followed by an in vitro transcription step to generate Biotin-16-UTP-labeled cRNA using the Ambion Illumina Total Prep RNA Amplification Kit (Ambion, Austin, TX, USA). The labeled probes were mixed with hybridization reagents and hybridized overnight to the HumanHT-12 v3 BeadChips (Illumina). Following washing and staining, the BeadChips were imaged using the Illumina BeadArray Reader (Illumina) to measure fluorescence intensity for each probe. The intensity of the signal corresponds to the quantity of the respective mRNA in the original sample. Quality check, background correction and normalization of the data were performed using Beadstudio expression module (Illumina). Differential gene expression was assessed using Genome Studio software (Illumina). A differential score X13 was considered statistically significant (Po0.05).
Functional annotations
Prioritized significant gene-lists were uploaded to DAVID (Database for Annotation, Visualization and Integrated Discovery; http://david.abcc. ncifcrf.gov/home.jsp) a web-based program useful to classify differentially expressed genes into biological categories or chromosomal localization. 17 The microarray data were MIAME compliant. 18 Validations of microarray data by real-time-quantitative PCR (RT-qPCR)
In all collected SAT samples, cDNAs were obtained from 1 mg of total RNA by reverse-transcription with SuperScript III (Invitrogen). At room temperature, 1 mg of total RNA was treated with DNaseI for 15 min. The reaction was incubated at 25 1C for 5 min, 42 1C for 30 min and 85 1C for 5 min, then stored at À 20 1C until use. We selected some differentially expressed genes to perform expression-level verification using RT-qPCR. This was done in the 7900 Real Time PCR System with TaqMan probes (Applied Biosystems, Foster City, CA, USA). Data were analyzed using the SDS v.1.4 software (Software Diversified Systems, Spring Lake Park, MN, USA). Cycle threshold (Ct) was defined as the cycle number at which a significant increase in the fluorescence signal was first detected. In each sample, mRNA levels were normalized to ribosomal protein large P0 (RPLP0) expression, producing a d Ct value. The relative quantization was then obtained by the 2^-DDCt method to determine the fold-change and expressed an AU (arbitrary units).
Characterization of adipose tissue morphology
For morphological studies, a fragment of each collected tissue sample was fixed in 4% formalin overnight at 4 1C and then paraffin embedded. For limited tissue availability, morphological determination was not performed in SAT samples from OW subjects. The size and density of adipocytes as well as blood vessels number were determined in hematoxylin/eosinstained sections using Image-Pro Plus 4.0 software (Media Cybernetics Europe, Marlow, Buckinghamshire, UK). For each sample, five randomly selected sectional areas, measuring at least 200 cell diameters, were analyzed and blood vessels counted and measured using an image analysis system (Image Analysis & Processing Software for Quantitative Microscopy Leica QWin, Leica Microsystems, Milan, Italy). Estimation of macrophage number was performed as previously described. 19 In brief, 5 mm sections were mounted on glass slides, deparaffinized in xylol and stained for CD68 using anti-CD68 monoclonal mouse anti-human antibody (Dako, Milan, Italy, dilution 1 : 100). Macrophages were identified in the adipose parenchyma (CD68 within blood vessels were excluded), when cytoplasmic staining for CD68 was present along with an identifiable mononuclear nucleus. Results are presented as the number of macrophages per 100 adipocytes (% macrophages). Fibrosis was estimated by Masson's trichrome staining kit (Bioptica, Milan, Italy) and a score was assigned for 10 randomly observed field (0, 1, 2 for a fibrosis area covering respectively the 5, 15 or 425% of the observed field) and expressed as mean±s.d. Images were acquired using an optical microscope coupled with a digital camera (Leica, Italy) and were analyzed using the software Image-Pro Plus 4.0.
Statistical analyses
The 'Detection Score' was used to determine expression levels using the Illumina Genome Studio software. This is a statistical measure based on the Adipose tissue in ex-obese subjects R Cancello et al Z-value of a gene relative to the Z-value of the negative controls. A gene with a detection P-value o0.05 was considered significantly expressed. The Illumina data were normalized using a cubic spline function. Genes with a nominal P-value o0.05 were considered statistically significant. Wilcoxon rank-test was used to compare mRNA expression levels in RT-qPCR validations. Differences between groups for mean diameter of adipocytes and biochemical data were calculated using Student's t-test for normally distributed data and nonparametric Mann-Whitney test when data appeared to be no normally distributed. All analyses were performed using Graphpad Prism software (La Jolla, CA, USA) and SPSS software (IBM, Milan, Italy). Data are expressed as mean values± s.d. A P-value o0.05 was considered statistically significant.
RESULTS
We studied SAT in a total of 58 subjects, regrouping them exclusively by body mass index (BMI) range, according to WHO classification: normal weight (NW patients with 20XBMIp25 ), overweight (OW, 254 BMI o30), obese (OB1-SAT: 30X BMIp34.9, OB2-SAT: 35X BMI p39.9, OB3-SAT: BMIX40). ExOB patients (N ¼ 10) had a mean BMI of 27.2±1.3 kg m
Microarray analysis Globally, a total of 37 796 genes, correspondent to 48 796 probes, were correctly detected after the scanning procedure. In all, 25 504 (67.5%) probes were identified by a Gene Symbol out of which 10 293 (17.8%) genes had an average signal detection with a P-value o0.05. When cluster analysis was applied to the significant genes, two main similarity clusters were identified: NW-SAT and OW-SAT on one hand and OB1-, OB2-, ExOB-and OB3-SAT on the other hand ( Figure 1) . Clustering is the most popular method used in the first step of gene expression analysis, allowing easier management of the microarray data set. The goal of clustering is to group together objects with similar properties. Intriguingly, the global expression profile of SAT in ExOB, despite a BMI index correspondent to an overweight range, showed a molecular 'distance' from the group of OW-SAT and, in contrast, a closer relationship with global gene expression profile observed in OB3-SAT (Figure 1 ). SAT molecular profiles of OB1 and OB2 patients were highly similar, as their position was in the same FTL  LOC642210  LOC648195  EE1A1  KIAA1881  C10orf116  TPT1  RPS25  LOC388720  OAZ1  RPL38  LOV441876  UBC  MYL6  LGALS1  RPS12  RPLP2  LOC388474  LOC401206  CD81  HBA2  HBB  JUND  MT1A  MT2A  NFKB1A  CRYAB  MT1X  LOC440589  RPS11  RPS16  LOC637361  RPS27  TMSB4X  RPL18A  LOC645899  RPS10  CFD  LOC441034  ANXA1  VWF  GPX4  VIM  LOC645683  RPL41  LAIR1  RPL27  TMSB10  CST3  APOD  RPL11  RPS27A   NW  OW  OB2  OB1 harm of the cluster (Figure 1 ). Gene expression profile of SAT from NW subjects was used as reference for differential expression analysis. In SAT from ExOB 646 gene were downregulated and 469 upregulated, while in SAT from OB3 subjects 1266 genes were downregulated and 940 upregulated. SAT from ExOB and OB3 patients shared 77% of the up-and downregulated genes. The first five clusters of functional annotations obtained by DAVID annotation tool, a Database for Annotation, Visualization and Integrated Discovery of microarray data, are shown in Figure 2 . In ExOB-SAT we observed an upregulation of genes related to apoptosis, cell activation in immune response, chemokine activity and a downregulation of genes related to DNA replication, replisome, RNA splicing and RNA transport. Interestingly, the functional annotations clusters for OB3-SAT were characterized by an upregulation of genes linked to apoptosis, chemokines activity, activation of innate immune response and downregulation of genes linked to respiratory chain complex, RNA transport, triglyceride metabolic process (such as domain WD, tryptophanaspartic acid dipeptide-repeat proteins). Randomly selected genes were analyzed by RT-qPCR in order to assess the quality of the array data analysis and a concordance between average mean signals from microarrays and RT-qPCR determinations was observed (data not shown).
Heat map analysis
We then performed an Heat Map analysis, that is a graphical representation of data where the individual significant average signal detection (AVG) are represented as colors (upregulated genes in red and downregulated genes in green) in order to have a quick visualization of genes with similar/different AVG in ExOB-and OB3-SAT. Among genes similarly regulated, we observed an upregulation of metallothionein genes (MT1A, MT2A) and NFkB gene, as shown in Figure 3 . This finding was confirmed by RT-qPCR ( Figure 4) . To verify the hypothesis of a tissue 'rescue' after weight loss, we then tested the expression of adiponectin gene, a gene well expressed in healthy adipose tissue. Surprisingly, adiponectin gene expression was downregulated in ExOB-SAT, despite the massive weight loss. The expression levels in ExOB-SAT were comparable to that of OB3-SAT samples ( Figure 4 ).
Morphological analysis
The collected SAT biopsies were analyzed by light microscopy in order to determine adipocyte hypertrophy, to evaluate the inflammatory infiltration and to estimate fibrosis level. As expected, adipocytes from ExOB-SAT were significantly less hypertrophic than those observed in OB3-SAT (Figure 5a ). Moreover, their mean size was not significantly different from that of NW-SAT adipocytes. Inflammatory cell infiltration, estimated by CD68 þ cell number, improved in SAT of ExOB patients when compared with that of OB3, as expected (Figure 5b ). However, crown-like structures were still clearly visible in ExOB-SAT samples (Figure 5d ). In contrast, fibrosis level was comparable in ExOB-and OB3-SAT samples (Figures 5c and e) .
DISCUSSION
In this study, we show for the first time that the global gene expression in abdominal SAT of ExOB patients is closely related to SAT gene expression of morbidly obese subjects. Moreover, global SAT gene expression of ExOB is not comparable to that of SAT from OW never obese subjects, despite these two groups share a comparable BMI. These results may indicate that BMI, the anthropometric indicator widely used to 'categorize' human obesity, is not representative of human SAT molecular signatures. This finding could be explained by several factors such as weight dynamical changes 20 and the number of diets. 21 Several studies have examined the effect of weight loss on human SAT overall gene expression; however, these studies varied in duration from few weeks to up to 1 year and reported the relationship between changes in adipose tissue gene expression and the nature and time of the intervention leading to the weight loss. 19, [22] [23] [24] The analysis of the molecular signature of SAT in ExOB patients that maintained a stable weight for at least 2 years represents both the strength and the novelty of the present study. Indeed, despite numerous studies on SAT gene expression profile previously published, to date there are no experimental data for such a long follow-up period. Nevertheless, we must underline that, as detailed clinical data of the enrolled patients were unavailable, these results are limited to adipose tissue molecular profile and, thus, their physiological significance needs to be supported by clinical observations in larger cohorts of morbidly obese patients. It is well known that SAT inflammatory genes are downregulated after short term very low calorie diet 22 and a clear improvement of this inflammatory profile in SAT is also achieved 3 months after a bariatric intervention. 19 It has also been demonstrated that SAT molecular signature after a longer weight loss follow-up (1 year) revealed a marked switch of homeobox transcription factor genes, a reduction in the inflammatory profile and an increase in collagen expression. 23 In ExOB-SAT we do not observe major molecular differences in comparison with OB3-SAT profile. The ExOB-SAT still preserves an 'obese molecular profile' in abdominal depot. Most probably this profile has a peculiar 'resistance' to easily disappear after weight loss and thus surgical removal may represent the only way to eliminate this still potentially dangerous adipose tissue.
We found metallothioneins (MT1A, MT2A) as commonly upregulated genes in both ExOB-and OB3-SAT. Metallothioneins are low molecular-weight cysteine-rich protein family, activated by a large variety of stimuli, such as metal exposure, oxidative stress, glucocorticoids, etc. [24] [25] [26] [27] Metallothioneins (especially the MT1 and MT2) have a crucial role in binding of metals, such as zinc and copper, and participate in the regulation of cellular metabolism of these metals. [24] [25] [26] [27] MT1 and MT2 are present in cells throughout the body and their gene transcription is rapidly induced by heavy metals as well as by oxidative stress.
24 MT1-MT2 possess antiapoptotic and anti-oxidant properties but their biological functions in adipose tissue have not been fully elucidated. It has been previously demonstrated that metallothioneins genes are expressed in human SAT and their expression levels, in both adipocytes and SVF cells, are significantly higher in obese subjects. 25 Interestingly, a 2-week period on a diet of 800 calories per day did not lead to any significant change in MT2 mRNA levels. 25 The results presented herein extend the meaning of these findings by demonstrating that metallothionein genes are not downregulated even after a massive weight loss and a long period of stable weight maintenance. Based on these considerations, it is tempting to speculate that this gene family may represent a new unsuspected marker of adipose tissue response to fat expansion and obesity, possibly also of adipose tissue fibrosis, the main morphologic feature still present even after a massive weight loss and weight stabilization. Future studies are needed to investigate the role of MTs in stress response and adipose tissue physiology.
Among the downregulated genes, we observed genes related to proliferation, RNA replication and secretory pathways. Additionally, also members of the WD-40 family of eukaryotic proteins involved in the regulation of intracellular signaling, RNA processing and degradation, gene expression, vesicular traffic and fusion, were downregulated. [28] [29] [30] [31] This is consistent with residual SAT being less capable to proliferate and to have an active metabolic role and is in agreement with the low level of adiponectin gene expression in ExOB-SAT. Adiponectin exerts important biological effects, especially in vascular network preserving endothelial function, protecting it from ischemic and reperfusion damage and stimulating angiogenesis. It also possesses anti-inflammatory, anti-apoptotic and anti-hypertrophic properties. Furthermore, it modulates inflammation, reducing the synthesis of pro-inflammatory cytokines, especially tumor necrosis factor a. It is tempting to speculate that ExOB-SAT hypoadiponectinemia could be linked to the persistent fibrosis still present even after a massive weight loss. Additionally, it is important to underline that we investigated exclusively adiponectin gene expression in SAT and we cannot exclude different expression levels in other adipose depots, such as VAT (visceral adipose tissue). VAT molecular differences depending on BMI remain to be determined, at present.
Morphologically ExOB-and OB3-SAT share a common fibrosis level despite significant differences in adipocyte hypertrophy and inflammatory infiltration. Fibrosis is now considered a new hallmark of adipose tissue histopathologic feature in obesity and a negative relationship was found between weight loss and fibrosis. 32 Additional studies are needed to follow the evolution of fibrotic depots and to better understand the role of collagen and ECM molecules during weight loss. In conclusion, the results of this study clearly demonstrate the permanence of some molecular features of morbid obesity in SAT even after an extensive and rapid weight loss and after reaching a stable phase of weight.
This may suggest that in abdominal ExOB-SAT, the molecular features induced by morbid obesity are not completely reverted by weight loss and may need longer time and/or direct intervention to completely disappear.
